Endpoints News 29 ene 2026 Sanofi says its €15B dealmaking budget, R&D spend should help ease looming Dupixent patent cliff
Endpoints News 28 ene 2026 FDA suspends Regenxbio gene therapy trials after patient developed brain tumor